Henoxol Capsule

Henoxol Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number: MAL20126088T
Type: Natural product
Published status: PRODUCT APPROVED
Licence holder: WHITE HERON PHARMACEUTICAL SDN. BHD.
Manufacturer: WHITE HERON PHARMACEUTICAL SDN. BHD.
Registration date: 2025-12-15
Published validity end: 2030-12-15

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Rheum palmatum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredient	Published text and quantity	Identified nutrient or substance
Sophora japonica	Sophora japonica[100 mg,500 mg]	Not identified
Sanguisorba officinalis	Sanguisorba officinalis[66 mg,500 mg]	Not identified
Scutellaria baicalensis	Scutellaria baicalensis[50 mg,500 mg]	Not identified
Sophora japonica	Sophora japonica[50 mg,500 mg]	Not identified
Citrus aurantium	Citrus aurantium[42 mg,500 mg]	Not identified
Angelica sinensis	Angelica sinensis[42 mg,500 mg]	Not identified
Schizonepeta tenuifolia	Schizonepeta tenuifolia[42 mg,500 mg]	Not identified
Rheum palmatum	Rheum palmatum[42 mg,500 mg]	Not identified
Saposhnikovia divaricata	Saposhnikovia divaricata[33 mg,500 mg]	Not identified
Paeonia lactiflora	Paeonia lactiflora[33 mg,500 mg]	Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants

Active ingredients: Sophora japonica[100 mg,500 mg],Sanguisorba officinalis[66 mg,500 mg],Scutellaria baicalensis[50 mg,500 mg],Sophora japonica[50 mg,500 mg],Citrus aurantium[42 mg,500 mg],Angelica sinensis[42 mg,500 mg],Schizonepeta tenuifolia[42 mg,500 mg],Rheum palmatum[42 mg,500 mg],Saposhnikovia divaricata[33 mg,500 mg],Paeonia lactiflora[33 mg,500 mg]
Valid until: 2030-12-15
Registration date: 2025-12-15
Published description: NATURAL PRODUCT
Licence holder: WHITE HERON PHARMACEUTICAL SDN. BHD.
Producer: WHITE HERON PHARMACEUTICAL SDN. BHD.
Published name: Henoxol Capsule
Published reference: 202007234006T
Registration number: MAL20126088T
Published status: PRODUCT APPROVED

Official source

View the official register, number MAL20126088T

Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.